BioXcel Is Bankrupt. Teva Is First in Line for IGALMI.
Nasdaq 30 Aug · 10:40

BioXcel Is Bankrupt. Teva Is First in Line for IGALMI.

Teva holds the opening bid in a court-supervised auction for substantially all of BioXcel's assets, including its only approved drug. Whoever wins also inherits a pending FDA decision due in November.

Read the story
Latest
How we work

Every article names the filing or release it came from. Read the source before acting on anything here.

Find them before we write about them.
Live screens — most active, gainers, losers and most volatile, US and Canada.
Open screener